MHCクラスI誘導技術を用いた新規膀胱癌免疫療法の開発

• Project/Area Number: 25K02512
• Research Category: Grant-in-Aid for Scientific Research (B)
• Allocation Type: Multi-year Fund
• Section: 一般
• Review Section: Basic Section 50010:Tumor biology-related
• Research Institution: Hokkaido University
• Principal Investigator: 小林 弘一 北海道大学, 医学研究院, 教授 (60817162)
• Project Period (FY): 2025-04-01 – 2028-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥18,720,000 (Direct Cost: ¥14,400,000、Indirect Cost: ¥4,320,000); Fiscal Year 2027: ¥7,280,000 (Direct Cost: ¥5,600,000、Indirect Cost: ¥1,680,000); Fiscal Year 2026: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000); Fiscal Year 2025: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)